Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02142530
Title Carfilzomib Plus Belinostat in Relapsed/Refractory NHL
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Massachusetts General Hospital
Indications

non-Hodgkin lymphoma

Therapies

Belinostat

Carfilzomib

Age Groups: adult
Covered Countries USA


No variant requirements are available.